4//SEC Filing
Allan Jonathan 4
Accession 0001966716-25-000004
CIK 0001623526other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:26 PM ET
Size
9.3 KB
Accession
0001966716-25-000004
Insider Transaction Report
Form 4
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-10-03−10,000→ 34,800 totalExercise: $9.15Exp: 2033-03-14→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2025-10-03$9.15/sh+10,000$91,500→ 21,831 total - Sale
Common Stock
2025-10-03$25.07/sh−10,000$250,650→ 11,831 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option vested or vests as to 1/48th of the total award on April 15, 2023, with an additional 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001966716
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:26 PM ET
- Size
- 9.3 KB